RGC Stock Summary and Trading Ideas (Regencell Bioscience Holdings Limited - | NASDAQ:RGC)

Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Regencell Bioscience Holdings Limited - trades on the NASDAQ stock market under the symbol RGC.

As of January 16, 2026, RGC stock price declined to $27.43 with 335,662 million shares trading.

RGC has a beta of -0.56, meaning it tends to be less sensitive to market movements. RGC has a correlation of 0.00 to the broad based SPY ETF.

RGC has a market cap of $13.56 billion. This is considered a Large Cap stock.

In the last 3 years, RGC traded as high as $83.60 and as low as $.08.

The top ETF exchange traded funds that RGC belongs to (by Net Assets): ONEQ, GXC.

RGC has outperformed the market in the last year with a price return of +21525.3% while the SPY ETF gained +18.1%. RGC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +52.8% and +33.5%, respectively, while the SPY returned +5.0% and +1.2%, respectively.

RGC support price is $24.61 and resistance is $35.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RGC shares will trade within this expected range on the day.